Key Capital Management
ABBV icon

Key Capital Management’s AbbVie ABBV Stock Holding History

Key Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$344K Buy
1,228
+945
+334% +$242K 0.13% 110
2026
Q2 		$71.2K Sell
283
-106
-27% -$22.8K 0.04% 134
2026
Q1 		$84.6K Buy
389
+81
+26% +$18K 0.06% 109
2025
Q4 		$70.4K Buy
+308
New +$70.2K 0.07% 109

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Key Capital Management's ABBV Position: Q3 2026 in Review

Key Capital Management increased its AbbVie (ABBV) stake by 334% in Q3 2026, buying an estimated $242K and bringing the position to 1,228 shares worth $344K. The position accounts for 0.13% of the portfolio, ranked #110.

Key Capital Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Key Capital Management held 1,228 shares of AbbVie worth $344K as of Q3 2026.
  • Key Capital Management bought 945 AbbVie shares in Q3 2026, an estimated $242K.
  • AbbVie made up 0.13% of Key Capital Management's portfolio in Q3 2026, its #110 holding.
  • Key Capital Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Key Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.